Surveillance strategy of atrophic gastritis and intestinal metaplasia in a country with a high prevalence of gastric cancer

Digestive Diseases and Sciences

Volumn 57, Issue 3, 2012, Pages 746-752

  Shin, Woon Geon ^a   Kim, Heung Up ^b   Song, Ho June ^c   Hong, Su Jin ^d   Shim, Ki Nam ^e   Sung, In Kyung ^f   Kim, Jae Gyu ^g  

^a Hallym University   (South Korea)

^b Jeju International University   (South Korea)

^c University of Ulsan College of Medicine   (South Korea)

^d Soonchunhyang University   (South Korea)

^e Ewha Womans University School of Medicine   (South Korea)

^f Konkuk University School of Medicine   (South Korea)

^g Chung Ang University   (South Korea)

Author keywords

Atrophic gastritis; Endoscopy; Gastric cancer; Metaplasia; Screening

Indexed keywords

ARTICLE; ATROPHIC GASTRITIS; CONTROLLED STUDY; DISEASE SURVEILLANCE; ENDOSCOPY; FOLLOW UP; HUMAN; INTESTINE METAPLASIA; KOREA; PHYSICIAN; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; STOMACH CANCER; SYMPOSIUM; AGED; CLASSIFICATION; ENTEROPATHY; ETHNOLOGY; FEMALE; GASTROINTESTINAL ENDOSCOPY; HEALTH CARE SURVEY; HEALTH SURVEY; MALE; MASS SCREENING; MEDICINE; METAPLASIA; METHODOLOGY; MIDDLE AGED; OBSERVER VARIATION; PATHOLOGY; RISK FACTOR; SOUTH KOREA; STATISTICS; STOMACH TUMOR;

AGED; ENDOSCOPY, GASTROINTESTINAL; FEMALE; FOLLOW-UP STUDIES; GASTRITIS, ATROPHIC; HEALTH CARE SURVEYS; HUMANS; INTESTINAL DISEASES; MALE; MASS SCREENING; MEDICINE; METAPLASIA; MIDDLE AGED; OBSERVER VARIATION; POPULATION SURVEILLANCE; PREVALENCE; REPUBLIC OF KOREA; RISK FACTORS; STOMACH NEOPLASMS;

EID: 84859501287     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/s10620-011-1919-0     Document Type: Article

References (36)

1. Correa P. Human gastric carcinogenesis: a multistep and multifactorial process-First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res. 1992;52: 6735-6740. (Pubitemid 23006271)
2. Lahner E, Bordi C, Cattaruzza MS, et al. Long-term follow-up in atrophic body gastritis patients: atrophy and intestinal metaplasia are persistent lesions irrespective of Helicobacter pylori infection. Aliment Pharmacol Ther. 2005;22:471-481. (Pubitemid 41248115)
3. de Vries AC, Haringsma J, Kuipers EJ. The detection, surveillance and treatment of premalignant gastric lesions related to Helicobacter pylori infection. Helicobacter. 2007;12:1-15. (Pubitemid 46105914)
4. Filipe MI, Muñoz N, Matko I, et al. Intestinal metaplasia types and the risk of gastric cancer: a cohort study in Slovenia. Int J Cancer. 1994;57:324-329. (Pubitemid 24168604)
5. You WC, Li JY, Blot WJ, et al. Evolution of precancerous lesions in a rural Chinese population at high risk of gastric cancer. Int J Cancer. 1999;83:615-619. (Pubitemid 29508039)
6. Uemura N, Okamoto S, Yamamoto S, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med. 2001;345:784-789.
7. Rokkas T, Filipe MI, Sladen GE. Detection of an increased incidence of early gastric cancer in patients with intestinal metaplasia type III who are closely followed up. Gut. 1991;32: 1110-1113.
8. Leung WK, Sung JJ. Review article: intestinal metaplasia and gastric carcinogenesis. Aliment Pharmacol Ther. 2002;16: 1209-1216.
9. Yearly report of Korea on cancer development (2007.1.1-2007. 12.31). Ministry of Health and Welfare for the Korean Government 2010.
10. Kim HJ, Choi BY, Byun TJ, et al. The prevalence of atrophic gastritis and intestinal metaplasia according to gender, age and Helicobacter pylori infection in a rural population. J Prev Med Public Health. 2008;41:373-379.
11. Whiting JL, Sigurdsson A, Rowlands DC, et al. The long term results of endoscopic surveillance of premalignant gastric lesions. Gut. 2002;50:378-381. (Pubitemid 34161055)
12. Dinis-Ribeiro M, Lopes C, da Costa-Pereira A, et al. A follow up model for patients with atrophic chronic gastritis and intestinal metaplasia. J Clin Pathol. 2004;57:177-182. (Pubitemid 38177758)
13. Lahner E, Caruana P, D'Ambra G, et al. First endoscopic-histologic follow-up in patients with body-predominant atrophic gastritis: when should it be doně Gastrointest Endosc. 2001;53: 443-448. (Pubitemid 33586752)
14. de Vries AC, van Grieken NC, Looman CW, et al. Gastric cancer risk in patients with premalignant gastric lesions: a nationwide cohort study in the Netherlands. Gastroenterology. 2008;134: 945-952. (Pubitemid 351451990)
15. Kim YS, Park HA, Kim BS, et al. Efficacy of screening for gastric cancer in a Korean adult population: a case-control study. J Korean Med Sci. 2000;15:510-515.
16. Nam SY, Choi IJ, Park KW, et al. Effect of repeated endoscopic screening on the incidence and treatment of gastric cancer in health screenees. Eur J Gastroenterol Hepatol. 2009;21:855-860.
17. Shiratori Y, Nakagawa S, Kikuchi A, et al. Significance of a gastric mass screening survey. Am J Gastroenterol. 1985;80: 831-834. (Pubitemid 16233527)
18. Tsubono Y, Hisamichi S. Screening for gastric cancer in Japan. Gastric Cancer. 2000;3:9-18. (Pubitemid 32182889)
19. Mori Y, Arita T, Shimoda K, et al. Effect of periodic endoscopy for gastric cancer on early detection and improvement of survival. Gastric Cancer. 2001;4:132-136. (Pubitemid 33123475)
20. Tashiro A, Sano M, Kinameri K, et al. Comparing mass screening techniques for gastric cancer in Japan. World J Gastroenterol. 2006;12:4873-4874. (Pubitemid 44323214)
21. Dan YY, So JB, Yeoh KG. Endoscopic screening for gastric cancer. Clin Gastroenterol Hepatol. 2006;4:709-716. (Pubitemid 43825816)
22. Park MJ, Kim DH, Lim SH, et al. Features of gastric neoplasm detected during the screening examination. Gut Liver. 2007; 1:33-39.
23. Lee KJ, Inoue M, Otani T, et al. Gastric cancer screening and subsequent risk of gastric cancer: a large-scale population-based cohort study, with a 13-year follow-up in Japan. Int J Cancer. 2006;118:2315-2321.
24. Kunisaki C, Ishino J, Nakajima S, et al. Outcomes of mass screening for gastric carcinoma. Ann Surg Oncol. 2006;13: 221-228. (Pubitemid 43157417)
25. Miyamoto A, Kuriyama S, Nishino Y, et al. Lower risk of death from gastric cancer among participants of gastric cancer screening in Japan: a population-based cohort study. Prev Med. 2007;44: 12-19. (Pubitemid 46073076)
26. Yoshida S, Yamaguchi H, Tajiri H, et al. Diagnosis of early gastric cancer seen as less malignant endoscopically. Jpn J Clin Oncol. 1984;14:225-241.
27. Hosokawa O, Miyanaga T, Kaizaki Y, et al. Decreased death from gastric cancer by endoscopic screening: association with a population-based cancer registry. Scand J Gastroenterol. 2008;43:1112-1115.
28. Carpenter HA, Talley NJ. Gastroscopy is incomplete without biopsy: clinical relevance of distinguishing gastropathy from gastritis. Gastroenterology. 1995;108:917-924.
29. Redéen S, Petersson F, Jönsson KA, et al. Relationship of gastroscopic features to histological findings in gastritis and Helicobacter pylori infection in a general population sample. Endoscopy. 2003;35:946-950.
30. Lin BR, Shun CT, Wang TH, et al. Endoscopic diagnosis of intestinal metaplasia of stomach-accuracy judged by histology. Hepatogastroenterology. 1999;46:162-166.
31. Graham DY, Rugge M. Clinical practice: diagnosis and evaluation of dyspepsia. J Clin Gastroenterol. 2010;44:167-172.
32. Rugge M, Meggio A, Pennelli G, et al. Gastritis staging in clinical practice: the OLGA staging system. Gut. 2007;56:631-636. (Pubitemid 46662927)
33. Kannel WB, McGee D, Gordon T. A general cardiovascular risk profile: the Framingham Study. Am J Cardiol. 1976;38:46-51.
34. Chang MC, Oh SK. Development of individual probabilities estimating program of major cancer in Koreans. J Korean Soc Med Inform. 2008;14:355-371.
35. Watabe H, Mitsushima T, Yamaji Y, et al. Predicting the development of gastric cancer from combining Helicobacter pylori antibodies and serum pepsinogen status: a prospective endoscopic cohort study. Gut. 2005;54:764-768. (Pubitemid 40732089)
36. Mukoubayashi C, Yanaoka K, Ohata H, et al. Serum pepsinogen and gastric cancer screening. Intern Med. 2007;46:261-266. (Pubitemid 46488392)